查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1832305

微生物检测市场（按应用、技术、最终用户、样本类型和生物体类型）—2025-2032 年全球预测

Bacteriological Testing Market by Application, Technology, End User, Sample Type, Organism Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年细菌学检测市场将成长至 291.1 亿美元，复合年增长率为 11.10%。

主要市场统计数据
基准年2024年 125.4亿美元
预计2025年 139.3亿美元
预测年份：2032年 291.1亿美元
复合年增长率（%） 11.10%

关于细菌学检测如何在复杂的操作环境中支援健康保护、工业品质和临床决策的权威概述

细菌学检测处于公共卫生保护、工业品质保证和临床决策的交汇点。有效的检测策略可以降低疫情爆发风险，保护供应链，并支持医疗保健、食品生产、製药、水务和环境监测项目的合规性。随着微生物检测方法的进步，相关人员如今期望快速的反应时间、更高的分析灵敏度以及清晰的解读框架，以便快速采取行动。因此，实验室和检测供应商正在平衡技术投资与严格的品质体系，以满足对可操作结果日益增长的需求。

本次应用评估概述了塑造现代细菌学检测的核心驱动因素：技术创新、监管压力、跨部门风险管理和营运效率。实验室正在将分子和定序技术整合到传统的基于培养的工作流程中，环境和工业用户需要可扩展的采样方案，以满足审核和认证需求。在这种演变的背景下，决策者必须优先考虑能力差距、员工能力和资料管治，以确保检测仍然是预防、诊断和合规工作中值得信赖的支柱。

技术整合、监管趋严性和营运弹性如何将细菌检测从诊断备份转变为策略性风险管理能力

由于技术、监管和市场力量的融合，微生物检测格局正在迅速变化，这些力量正在重塑组织检测和管理微生物风险的方式。分子诊断技术的进步，例如更快的即时扩增和更便捷的定序，使得更早、更特异性检测病原体成为可能。同时，自动化培养系统和改进的选择性培养基正在减轻劳动力负担，并提高常规监测的可重复性。这些互补的功能正在推动从纯粹的确认性检测向预测性和预防性应用的转变，在这些应用中，数据可以为上游管理提供资讯。

监管要求和认证预期日益严格，促使实验室网路和行业运营商投资检验的工作流程和强大的品管系统。环境监测计画正从零星采样转向持续的、基于风险的策略，整合空气、土壤、地表和水质检测。该行业也在应对供应链压力和对弹性采购模式的需求，重点关注互通性、数位化报告和模组化实验室设计。总而言之，这些转型正在提升细菌学检测作为一项策略职能而非纯粹的技术活动的作用。

分析近期关税变化如何重塑美国细菌检测相关人员的采购、供应商策略和业务连续性

2025年美国关税计画的变化正在影响细菌学检测所用实验室设备、耗材和试剂的采购筹资策略、全球供应链和成本结构。进口关税和分类的更新可能会影响自动化设备、选择性培养基、分子检测套件和定序耗材的到岸成本，促使采购团队重新评估整体拥有成本和供应商多元化。在许多情况下，实验室主任和采购经理正在采用多供应商筹资策略并增加库存缓衝，以便在关税引发的价格波动期间保持检测业务的连续性。

除了直接的成本影响外，关税还加速了关于国内製造、战略采购伙伴关係以及合约保护措施的讨论，这些措施旨在降低关税突然调整带来的风险。相关人员也在重新审视设备标准化和互通性，以便在供应中断时进行零件替换。因此，企业正在优先考虑供应商风险评估、涉及关税转嫁的合约条款以及情境规划，以维持合规性和不间断的检测服务。这些调整反映了对政策主导的市场动态的务实应对，同时维护了其细菌检测项目的完整性。

关键细分洞察揭示了不同应用、技术、最终用户、样本类型和生物分类的优先顺序差异，从而实现有针对性的决策

细分主导的洞察揭示了不同应用领域、技术类型、最终用户、样本类型和生物群体在测试优先顺序、技术采用和服务交付模式方面存在巨大差异。临床诊断强调诊断的准确性和速度；体外诊断和 POC 测试优先考虑快速分子和免疫检测方法，而实验室开发的测试为利基病原体提供了灵活性。环境监测要求在强调长期监测的空气品质采样和土壤测试技术之间取得平衡；食品和饮料安全计划侧重于乳製品、肉类和已调理食品基质，需要培养确认和快速检测以保持供应链的完整性。製药和生物技术用户要求对最终产品和成分进行经过验证的测试，以符合严格的监管要求；水质检测涵盖饮用水和污水通讯协定，以支持公共卫生和公共产业合规性。

从技术角度来看，培养检测仍然是确认和敏感性分析的基础，并透过自动化系统和选择性培养基进行增强以提高通量。免疫检测广泛用于筛检，酵素结合免疫吸附试验和横向流动形式在灵敏度和易操作性之间提供了不同的权衡。下一代定序透过靶向和全基因组方法提供生物体的详细表征，从而实现疫情取证和抗药性菌株追踪，而数位 PCR 和即时PCR等聚合酵素链锁反应形式则以定量准确性加速检测。快速检测平台，无论是快速免疫检测或快速分子检测法，都支援近患者和现场决策。环境机构和水质净化水厂优先考虑合规性和环境监测；食品加工厂强调污染预防和产品放行测试；医院和诊断实验室优先考虑临床敏感性和工作流程整合；製药商要求进行严格的验证。样本类型（血液、食物基质、表面拭子、尿液、水）决定了采样通讯协定、分析前处理和分析方法的选择，而细菌、真菌、寄生虫和病毒的生物型分类则决定了检测设计和解读标准。了解这些层级划分有助于组织协调投资、最佳化方法选择，并设计出符合营运和监管目标的采样方案。

细緻地检查不同地区在优先事项和基础设施方面的差异如何导致细菌学检测的采用和能力建设方面的差异。

区域动态正在影响全球细菌学检测的优先顺序、资金投入和监管方式，不同地域市场呈现不同的驱动因素和采用模式。在美洲，相关人员优先考虑快速采用先进的诊断技术和综合实验室网络，以支援公共卫生监测和成熟的私人医疗保健部门。实验室现代化和商业性诊断合作伙伴关係的投资很常见，法律规范也在不断改进，以应对新出现的微生物威胁。在欧洲、中东和非洲，不同伙伴关係在监管协调、能力建设和基础设施方面的投资差异很大，一些国家大力推行标准化品管，而另一些国家则优先考虑基本的监测和培训计画。跨境合作和资金投入是扩大侦测管道和加强该地区疫情防范的重要槓桿。

亚太地区的特点是自动化培养系统、分子诊断和大规模环境监测计画的快速应用，其需求在工业扩张和都市化推动下呈现多元化但快速成长的态势。该地区的多个市场正在大力投资本地生产和劳动力发展，以支持国内检测能力并减少对进口的依赖。在整个地区，资料系统的互通性、数位化报告和统一的检验实践正成为跨辖区监控和事件回应的核心。这些区域洞察凸显了製定能够反映当地法规环境、资源限制和公共卫生优先事项的客製化部署策略的必要性。

深入了解成功的细菌学检测公司的竞争策略、合作模式和营运重点

关键公司洞察凸显了细菌检测领域成功企业在竞争和扩张方面所采用的策略方法。市场领先的公司通常将强大的研发能力与有针对性的伙伴关係相结合，以扩展其检测产品组合併加快产品上市速度。许多公司也正在投资模组化实验室平台和数位彙报解决方案，以促进互通性并简化不同终端用户的部署。策略性收购仍然是获取利基技术、扩大地域覆盖范围以及填补定序、自动化和快速检测领域能力缺口的常见途径。

服务供应商和合约测试实验室凭藉其专业的应用专长、快速的周转时间以及符合客户和监管要求的认证品质体系，脱颖而出。提供全面技术支援、培训计划和检验的工作流程的供应商往往能够深入渗透医院、营业单位和製药商等机构客户。此外，在关税和物流波动威胁业务连续性的时期，专注于本地化製造和供应链弹性的公司正在获得发展。总而言之，这些竞争态势表明，技术广度、监管合规性和以客户为中心的服务模式能够带来显着的市场优势。

领导者可以实施的具体、优先建议，以增强实验室的弹性，提高检测效能，并确保监管准备就绪

产业领导者可以采取明确可行的措施，增强实验室的韧性，提升检测能力，并使检测项目与策略目标保持一致。优先投资整合分子和基于培养的方法，以平衡速度和确认的确定性，并采用经过检验的通讯协定标准化工作流程，以简化培训并减少差异性。加强供应商关係，并围绕定价和供应连续性实施合约保障措施，以降低与关税和全球物流相关的中断风险​​。同时，投资数据互通性和数位化彙报，将侦测结果转化为支持事件回应和持续改进的及时情报。

员工队伍建立同样重要。有针对性的培训、交叉培训和能力评估使负责人能够操作先进的平台并解读复杂的分子或定序结果。实施基于风险的采样框架可以透过将检测重点放在高影响矩阵和关键控制点上来优化资源配置。最后，与监管机构和认证机构保持积极沟通，预测变化，并主动定位检测项目，以促进合规和公共卫生伙伴关係。这些策略行动使组织能够将检测能力转化为可证明的商业价值和声誉。

混合方法研究设计的透明描述，结合专家访谈、监管审查和技术映射，以获得可行的见解

本分析背后的调查方法融合了定性和定量分析，以确保研究的稳健性和有效性。主要研究包括访谈实验室管理人员、品管、采购负责人以及临床、环境、食品安全、製药和水务领域的专家，以获得第一手的营运挑战和技术偏好洞察。次要研究则检视了监管指南、标准、同行评审文献、行业出版物和公开的技术文檔，以检验趋势和技术发展。

此分析框架整合了技术采用情况图谱、应用和最终用户細項分析以及供应商能力评估，以整合横向洞察。我们进行了资料来源三角检验，并与业界从业者进行了迭代检验，以最大程度地减少偏差并提高实际适用性。这项流程确保研究结果能够反映营运实际情况、产业差异以及细菌学检测领域的最新方法进展，而无需依赖推测性预测模型。

结论性总结强调了综合检查方法、供应弹性和持续的作战安全人员准备的战略重要性

总而言之，细菌学检测正在从一项确认性检测功能发展成为一项策略能力，为多个部门的预防、合规和营运决策提供资讯。技术融合——分子诊断、定序和自动化技术对传统培养方法的补充——使得检测速度更快、更准确，同时也提高了对品质系统和员工能力的期望。政策和供应链动态，例如不断变化的关税和采购压力，迫使企业重新评估其采购、库存策略和供应商关係，以确保业务连续性并控製成本。

为了在不断变化的环境中保持高效，相关人员必须采用整合的检测策略，使方法选择与应用需求保持一致，投资于互通性和数据驱动的工作流程，并与监管机构和行业合作伙伴保持积极主动的沟通。如此一来，组织不仅可以提高检测和应对微生物风险的能力，还能将检测转化为对营运韧性和公共卫生保护的可衡量贡献。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 将快速核酸增幅检查整合到照护现场诊断工作流程中
  • 引进自动化、高性能细菌培养系统以提高实验室效率
  • 临床实验室对结合细菌学和病毒学检测的多病原体检测的需求日益增加
  • 人工智慧演算法在细菌敏感性数据自动解释的应用
  • 人们对数微流体在护理点快速抗生素抗药性分析中的兴趣日益浓厚
  • 社区层级细菌病原体监测趋势日益重视废水监测
  • 透过诊断实验室和医院之间的合作，在农村地区开发分散的细菌检测平台
  • 扩大次世代定序在细菌感染丛集流行病学追踪的应用

第六章 2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章微生物检测市场的应用

  • 临床诊断
    • 体外诊断
    • 实验室开发的测试
    • 就地检验
  • 环境监测
    • 空气品质
    • 土壤样本采集
  • 食品和饮料安全
    • 乳製品
    • 肉品
    • 即食产品
  • 製药和生物技术
    • 最终产品
    • 原料
  • 水质检测
    • 饮用水
    • 污水

第九章微生物检测市场（依技术）

  • 文化测试
    • 自动化系统
    • 选择性培养基
  • 免疫检测
    • 酵素结合免疫吸附试验
    • 横向流动化验
  • 下一代定序
    • 目标序列
    • 全基因组序列分析
  • 聚合酵素链锁反应
    • 数位PCR
    • 即时PCR
  • 快速检测
    • 快速免疫检测
    • 快速分子测量

第 10 章微生物学检测市场（按最终用户划分）

  • 环境机构
  • 食品加工设施
  • 医院和诊断实验室
  • 製药商
  • 水处理厂

第 11 章微生物学检测市场（依样本类型）

  • 血液样本
  • 食品样品
  • 表面拭子
  • 尿液样本
  • 水样

第 12 章微生物检测市场（依生物体类型）

  • 细菌
  • 真菌
  • 寄生虫
  • 病毒

第十三章微生物检测市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章微生物检测市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国微生物检测市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Thermo Fisher Scientific, Inc.
    • Danaher Corporation
    • bioMerieux SA
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Siemens Healthineers AG
    • QIAGEN NV
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
Product Code: MRR-437D45957E5D

The Bacteriological Testing Market is projected to grow by USD 29.11 billion at a CAGR of 11.10% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 12.54 billion
Estimated Year [2025] USD 13.93 billion
Forecast Year [2032] USD 29.11 billion
CAGR (%) 11.10%

An authoritative overview of how bacteriological testing underpins health protection, industrial quality, and clinical decision-making in complex operational environments

Bacteriological testing stands at the intersection of public health protection, industrial quality assurance, and clinical decision-making. Effective testing strategies reduce outbreak risks, safeguard supply chains, and support regulatory compliance across healthcare, food production, pharmaceutical manufacturing, water utilities, and environmental monitoring programs. As microbial detection methodologies have advanced, stakeholders now expect faster turnaround, greater analytical sensitivity, and clearer interpretation frameworks to inform rapid action. Consequently, laboratories and testing providers are balancing investments in technology with rigorous quality systems to meet the rising demand for actionable results.

This introduction outlines core drivers shaping contemporary bacteriological testing: technological innovation, regulatory pressure, cross-sector risk management, and operational efficiency. Laboratories are integrating molecular and sequencing techniques into traditional culture-based workflows, while environmental and industrial users require scalable sampling programs that align with audit and certification needs. Against this evolving backdrop, decision-makers must prioritize capability gaps, workforce competency, and data governance to ensure testing remains a reliable pillar of prevention, diagnosis, and compliance efforts.

How technological convergence, regulatory tightening, and operational resilience are transforming bacteriological testing from diagnostic backstop to strategic risk management capability

The landscape of bacteriological testing has shifted rapidly due to converging technological, regulatory, and market forces that are reshaping how organizations detect and manage microbial risks. Advances in molecular diagnostics, including faster real-time amplification and more accessible sequencing, are enabling earlier and more specific detection of pathogens. At the same time, automated culture systems and improved selective media are reducing labor burden and enhancing reproducibility for routine surveillance. These complementary capabilities are catalyzing a transition from purely confirmatory testing to predictive and preventive applications where data informs upstream controls.

Regulatory requirements and accreditation expectations have tightened, prompting laboratory networks and industrial operators to invest in validated workflows and robust quality management systems. Environmental monitoring programs are moving from sporadic sampling to continuous, risk-based strategies that integrate air, soil, surface, and water testing. The industry is also responding to supply chain pressures and the need for resilient procurement models, with an emphasis on interoperability, digital reporting, and modular laboratory design. Taken together, these transformative shifts are elevating the role of bacteriological testing as a strategic function rather than a purely technical activity.

An analysis of how recent tariff shifts are reshaping procurement, supplier strategies, and operational continuity for bacteriological testing stakeholders in the United States

Tariff policy changes in the United States for 2025 are influencing procurement strategies, global supply chains, and cost structures for laboratory equipment, consumables, and reagents used in bacteriological testing. Import duties and classification updates can affect the landed cost of automated instruments, selective media, molecular assay kits, and sequencing consumables, prompting procurement teams to reassess total cost of ownership and vendor diversification. In many cases, laboratory directors and procurement managers are adopting multi-vendor sourcing strategies and increasing inventory buffers to maintain continuity of testing operations during periods of tariff-driven price volatility.

Beyond direct cost implications, tariffs are accelerating conversations around domestic manufacturing, strategic sourcing partnerships, and contractual protections that mitigate exposure to sudden tariff adjustments. Stakeholders are also revisiting instrument standardization and cross-compatibility to enable substitution of components when supply disruption occurs. As a result, organizations increasingly prioritize supplier risk assessments, contractual clauses that address tariff pass-through, and scenario planning to maintain compliance and uninterrupted testing services. These adaptive measures reflect a pragmatic response to policy-driven market dynamics while preserving the integrity of bacteriological testing programs.

Essential segmentation insights that illuminate differential priorities across applications, technologies, end users, sample types, and organism classifications for targeted decision making

Segmentation-driven insights reveal substantive differences in testing priorities, technology adoption, and service delivery models across application areas, technology types, end users, sample types, and organism groups. In clinical diagnostics, the focus centers on diagnostic accuracy and speed, with in vitro diagnostics and point of care testing prioritizing rapid molecular and immunoassay approaches, while laboratory developed tests provide flexibility for niche pathogens. Environmental monitoring requires a balance of air quality sampling and soil testing techniques that emphasize longitudinal surveillance, and food and beverage safety programs concentrate on dairy, meat, and ready-to-eat matrices that demand both culture confirmation and rapid detection to preserve supply chain integrity. Pharmaceutical and biotech users demand validated testing for final products and raw materials that align with stringent regulatory expectations, and water testing spans drinking water and wastewater protocols that support public health and utility compliance.

From a technology perspective, culture testing remains foundational for confirmation and susceptibility profiling, augmented by automated systems and selective media to improve throughput. Immunoassays are used widely for screening, with enzyme linked immunosorbent assays and lateral flow formats delivering different trade-offs between sensitivity and operational simplicity. Next generation sequencing provides deep characterization of organisms through targeted and whole genome approaches, enabling outbreak forensics and resistance tracking, while polymerase chain reaction modalities such as digital and real time PCR accelerate detection with quantitative precision. Rapid detection platforms, whether rapid immunoassay or rapid molecular, are enabling near-patient and on-site decision making. End users vary widely in capability and need: environmental agencies and water treatment plants often emphasize compliance and ambient surveillance, food processing facilities focus on contamination prevention and product release testing, hospitals and diagnostic laboratories prioritize clinical sensitivity and workflow integration, and pharmaceutical manufacturers require tightly validated processes. Sample type considerations-blood, food matrices, surface swabs, urine, and water-drive sampling protocols, pre-analytical handling, and method selection, while organism type classification among bacteria, fungi, parasites, and viruses informs assay design and interpretive criteria. Understanding these layered segmentations helps organizations tailor investments, optimize method selection, and design sampling programs that meet both operational and regulatory objectives.

A nuanced exploration of how distinct regional priorities and infrastructure differences are driving variation in bacteriological testing adoption and capability development

Regional dynamics are shaping how bacteriological testing is prioritized, funded, and regulated across the globe, with geographic markets exhibiting distinct drivers and adoption patterns. In the Americas, stakeholders emphasize rapid adoption of advanced diagnostics and integrated laboratory networks that support public health surveillance and a mature private healthcare sector. Investment in laboratory modernization and commercial diagnostic partnerships is common, and regulatory frameworks are continually refined to address emerging microbial threats. In Europe, the Middle East and Africa, regulatory harmonization, capacity building, and infrastructure investment vary considerably across jurisdictions, with some countries driving strong adoption of standardized quality management while others prioritize foundational surveillance and training programs. Cross-border collaboration and funding initiatives are important levers for expanding testing access and strengthening outbreak preparedness in the region.

The Asia-Pacific region demonstrates heterogeneous but fast-moving demand, characterized by rapid uptake of automated culture systems, molecular diagnostics, and large-scale environmental monitoring programs driven by industrial expansion and urbanization. Several markets in the region are investing heavily in local manufacturing and workforce training to support domestic testing capacity and reduce reliance on imports. Across all regions, interoperability of data systems, digital reporting, and harmonized validation practices are becoming central to cross-jurisdictional surveillance and incident response. These regional insights underscore the need for tailored deployment strategies that reflect local regulatory environments, resource constraints, and public health priorities.

Insightful analysis of competitive strategies, partnership models, and operational priorities that distinguish successful companies in bacteriological testing

Key company insights underscore strategic approaches that successful organizations use to compete and scale within the bacteriological testing landscape. Market leaders often combine strong R&D capabilities with targeted partnerships to broaden assay portfolios and accelerate time to market. Many also invest in modular laboratory platforms and digital reporting solutions that facilitate interoperability and ease of adoption across diverse end users. Strategic acquisitions remain a common pathway to acquiring niche technologies, expanding geographical footprints, and filling capability gaps in sequencing, automation, or rapid detection.

Service providers and contract laboratories differentiate through specialized application expertise, rapid turnaround times, and accredited quality systems that meet customer and regulator expectations. Suppliers that offer comprehensive technical support, training programs, and validated workflows tend to achieve deeper penetration into institutional customers such as hospitals, water utilities, and pharmaceutical manufacturers. Additionally, companies focusing on localized manufacturing and supply chain resilience are gaining traction where tariff or logistical volatility threatens continuity. Collectively, these competitive behaviors reflect a market where technology breadth, regulatory alignment, and customer-centric service models provide meaningful advantage.

Concrete and prioritized recommendations that leaders can implement to fortify laboratory resilience, improve detection performance, and ensure regulatory readiness

Industry leaders can take clear, actionable steps to strengthen laboratory resilience, improve detection capabilities, and align testing programs with strategic goals. Prioritize investments that integrate molecular and culture-based methods to balance speed with confirmatory certainty, and standardize workflows with validated protocols to streamline training and reduce variability. Strengthening supplier relationships and implementing contractual safeguards around pricing and supply continuity will mitigate disruption risks related to tariffs and global logistics. In parallel, invest in data interoperability and digital reporting to transform test results into timely intelligence that supports incident response and continuous improvement.

Workforce development is equally important; targeted training, cross-training, and competency assessments ensure that personnel can operate advanced platforms and interpret complex molecular or sequencing outputs. Implementing risk-based sampling frameworks will optimize resource allocation by focusing testing on high-impact matrices and critical control points. Finally, maintain active engagement with regulators and accreditation bodies to anticipate changes and position testing programs proactively for compliance and public health partnerships. These strategic actions enable organizations to convert testing capability into demonstrable operational and reputational value.

A transparent explanation of the mixed methods research design combining expert interviews, regulatory review, and technology mapping to derive actionable insights

The research methodology underpinning this analysis blends qualitative and quantitative approaches to ensure robustness and relevance. Primary interviews were conducted with laboratory directors, quality managers, procurement officers, and subject matter experts across clinical, environmental, food safety, pharmaceutical, and water sectors to capture firsthand operational challenges and technology preferences. Secondary research included a review of regulatory guidance, standards, peer-reviewed literature, trade publications, and publicly available technical materials to validate trends and technological developments.

Analytical frameworks incorporated technology adoption mapping, segmentation analysis by application and end user, and supplier capability assessments to synthesize cross-cutting insights. Triangulation of data sources and iterative validation with industry practitioners were used to minimize bias and enhance practical applicability. Throughout the process, care was taken to ensure that findings reflect operational realities, sectoral nuances, and the latest methodological advances in bacteriological testing without relying on speculative forecasting models.

A decisive wrap-up highlighting the strategic importance of integrated testing approaches, supply resilience, and workforce readiness for sustained operational security

In conclusion, bacteriological testing is evolving from a confirmatory laboratory function into a strategic capability that informs prevention, compliance, and operational decision making across multiple sectors. Technology convergence-where molecular diagnostics, sequencing, and automation complement traditional culture methods-is enabling faster, more precise detection while also raising expectations around quality systems and workforce competency. Policy and supply chain dynamics, including tariff shifts and procurement pressures, are prompting organizations to rethink sourcing, inventory strategies, and supplier relationships to protect continuity and manage costs.

To remain effective in this changing environment, stakeholders must adopt integrated testing strategies that align method selection with application needs, invest in interoperability and data-driven workflows, and maintain proactive engagement with regulators and industry partners. By doing so, organizations will not only improve their capacity to detect and respond to microbial risks but also transform testing into a measurable contributor to operational resilience and public health protection.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of rapid nucleic acid amplification tests in point-of-care diagnostic workflows
  • 5.2. Adoption of automated high-throughput bacterial culture systems to improve lab efficiency
  • 5.3. Growing demand for multiplex pathogen assays combining bacteriological and viral detection in clinical labs
  • 5.4. Implementation of artificial intelligence algorithms for automated interpretation of bacterial susceptibility data
  • 5.5. Rising interest in digital microfluidics for rapid antibiotic resistance profiling at the point of care
  • 5.6. Increasing focus on wastewater surveillance for community-level bacteriological pathogen monitoring trends
  • 5.7. Collaboration between diagnostics labs and hospitals to deploy decentralized bacteriological testing platforms in rural areas
  • 5.8. Expansion of next generation sequencing applications for epidemiological tracking of bacterial outbreak clusters

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bacteriological Testing Market, by Application

  • 8.1. Clinical Diagnostics
    • 8.1.1. In Vitro Diagnostics
    • 8.1.2. Laboratory Developed Tests
    • 8.1.3. Point Of Care Testing
  • 8.2. Environmental Monitoring
    • 8.2.1. Air Quality
    • 8.2.2. Soil Sampling
  • 8.3. Food And Beverage Safety
    • 8.3.1. Dairy Products
    • 8.3.2. Meat Products
    • 8.3.3. Ready To Eat Products
  • 8.4. Pharmaceutical And Biotech
    • 8.4.1. Final Products
    • 8.4.2. Raw Materials
  • 8.5. Water Testing
    • 8.5.1. Drinking Water
    • 8.5.2. Wastewater

9. Bacteriological Testing Market, by Technology

  • 9.1. Culture Testing
    • 9.1.1. Automated Systems
    • 9.1.2. Selective Media
  • 9.2. Immunoassay
    • 9.2.1. Enzyme Linked Immunosorbent Assay
    • 9.2.2. Lateral Flow Assay
  • 9.3. Next Generation Sequencing
    • 9.3.1. Targeted Sequencing
    • 9.3.2. Whole Genome Sequencing
  • 9.4. Polymerase Chain Reaction
    • 9.4.1. Digital PCR
    • 9.4.2. Real Time PCR
  • 9.5. Rapid Detection
    • 9.5.1. Rapid Immunoassay
    • 9.5.2. Rapid Molecular

10. Bacteriological Testing Market, by End User

  • 10.1. Environmental Agencies
  • 10.2. Food Processing Facilities
  • 10.3. Hospitals And Diagnostic Laboratories
  • 10.4. Pharmaceutical Manufacturers
  • 10.5. Water Treatment Plants

11. Bacteriological Testing Market, by Sample Type

  • 11.1. Blood Samples
  • 11.2. Food Samples
  • 11.3. Surface Swabs
  • 11.4. Urine Samples
  • 11.5. Water Samples

12. Bacteriological Testing Market, by Organism Type

  • 12.1. Bacteria
  • 12.2. Fungi
  • 12.3. Parasites
  • 12.4. Viruses

13. Bacteriological Testing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bacteriological Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bacteriological Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific, Inc.
    • 16.3.2. Danaher Corporation
    • 16.3.3. bioMerieux SA
    • 16.3.4. F. Hoffmann-La Roche AG
    • 16.3.5. Abbott Laboratories
    • 16.3.6. Siemens Healthineers AG
    • 16.3.7. QIAGEN N.V.
    • 16.3.8. Becton, Dickinson and Company
    • 16.3.9. Bio-Rad Laboratories, Inc.
    • 16.3.10. Merck KGaA

LIST OF FIGURES

  • FIGURE 1. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BACTERIOLOGICAL TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BACTERIOLOGICAL TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BACTERIOLOGICAL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY GROUP, 2025-2032 (USD MILLION